Early ureteric stent removal reduces urinary tract infection in kidney transplant recipients, A Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12610000310066

Acronym

UTI-S

Enrollment

130

Registered

2010-04-19

Start date

2010-04-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine the potential benefit and harmful of early ureteric stent removal (7 days) compare with routine ureteric stent removal (14 days) in kidney transplant recipient.

Interventions

Early ureteric stent removal (7 days)

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

Adult patients who undergo for kidney transplant (both living related and cadaveric)

Exclusion criteria

1. Patient who has history of reflux nephropathy or neurogenic lower urinary tract disease 2. Abnormal structure of kidney donor 3. Cold ischemic time > 36 hours 4. Patient who has abnormal urinary tract 5. En bloc kidney from pediatric donor 6. Patient who has difficult intraoperative technique (eg. Small caliber ureter) that defined by urologist 7. Patient who receive antibiotic other than standard regiemen 8. Patient who denied for inform and consent

Outcome results